William H. Frishman, M.D., is an internist and cardiologist with a research interest in cardiovascular pharmacology, clinical epidemiology, and geriatrics. Dr. Frishman has authored and co-authored more than 900 original articles, reviews, and book chapters. He has also edited, co-edited, authored, and co-authored twelve full-length textbooks, including the major text Cardiovascular Pharmacotherapeutics (McGraw-Hill), now in its second edition. Dr. Frishman published three books: Complementary and Integrative Therapies for Cardiovascular Disease (Elsevier 2005), Cardiovascular Regeneration and Stem Cell Therapy (Blackwell Futura, 2007), and Hypertension: A Clinical Guide (Lippincott, 2007). He is also the supplements editor for the American Journal of Medicine and a co-editor of the journal Cardiology in Review and the Yearbook of Medicine.

Education

  • M.D., Boston University School of Medicine

Areas of Expertise

  • Cardiovascular Pharmacology
  • Clinical Epidemiology 
  • Geriatrics

Honors and Awards

  • Teaching Scholar Award of the American Heart Association
  • Preventative Cardiology Academic Award from the National Heart, Lung and Blood Institute
  • Distinguished Teacher Award, Alpha Omega Alpha National Medical Honor Society

Research

Dr. Frishman has served as a principal investigator in multiple NIH-funded studies, including the "Systolic Hypertension in the Elderly" (SHEP) Trial, the "Studies of Left Ventricular Dysfunction" (SOLVD), the "Women's Health Initiative Trial" (WHI), and the "Bronx Longitudinal Aging Study."

Publications

  • Salama B, Hodhod A, Bassiony M, et. al. "Intravascular Lithotripsy for Calcified Vascular Lesions: Mechanisms, Techniques, Clinical Applications, and Future Directions." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001478
  • Sigalov A, Frishman WH. "Cardiometabolic Risk Reduction Through Selective Amylin Receptor Agonism: Emerging Cardiovascular Implications of Eloralintide." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001468
  • Kozyk M, Strubchevska O, Strubchevska K, et. al. "Gamma-Glutamyl Transferase at the Crossroads of Cardiometabolic Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001474
  • Karthikeyan A, Alper A, Karp A, et. al. "Discontinuation of Oral Anticoagulation After Successful Atrial Fibrillation Ablation: A Meta-Analysis of Randomized Controlled Trials." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001458
  • Kaywood AJ, Ahmadi A, Frishman WH, et. al. "Management of Patent Ductus Arteriosus in the Adult Population." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001470
  • Thapa S, Shah S, Fnu P, et. al. "Left Atrial Strain Impairment in Embolic Stroke of Undetermined Source: A Systematic Review and Meta-Analysis." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001434
  • Pillai AA, Mehta A, Godin SL, et. al. "Menopausal Hormone Therapy and Cardiovascular Risk: Current Evidence and Treatment Recommendations." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001464
View All Publications